Found 211 clinical trials
ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease
The purpose of this study is to evaluate the safety and efficacy of the ExAblate Model 4000 Type 2.0 System as a tool to disrupt the blood-brain barrier (BBB) in patients with probable Alzheimer's Disease (AD).
- 0 views
- 22 Sep, 2024
- 3 locations
2 march edit9
This is a randomized, open-label, parallel group study to determine the optimal dose of CART-19 cells (of the two dose levels being assessed (1-5x10xE8 vs. 1-5x10xE7 CART-19 cells). This trial will be conducted in two stages. In Stage 2, the selected dose cohort will be expanded to enroll additional subjects, …
- 0 views
- 26 Sep, 2024
- 1 location
iConnect R12.3 UAT Dry Run Script 03-1
iConnect R12.3 UAT Dry Run Script 05-1<br>
- 0 views
- 10 Jan, 2025
- 1 location
iConnect R12.3.1 UAT Dry Run for Site Question
iConnect R12.3.1 UAT Dry Run for Site Question
- 0 views
- 17 Apr, 2024
- 2 locations